Friday 11 Apr, 2025 02:02 AM
Site map | Locate Us | Login
   TCS' net profit slips 1.26% QoQ in Q4 FY25; final dividend at Rs 30/shr    Madhav Infra Projects acquires 100% stake in MSK Projects (I)    Jindal Stainless arm signs power purchase agreement with Sunsure Energy    Rites inks MoU with DP World for logistics infrastructure development    Avalon Tech board approves investment in Zepco Technologies    Oriental Rail Infra secures Rs 4-cr order from Indian Railways    Olectra Greentech bags LoA worth Rs 421 cr from Himachal Road Transport Corp    Biocon unit gets U.S. FDA nod for cancer drug biosimilar    JSW Energy arm acquires renewable energy platform for Rs 12,468-cr    Coromandel Intl inks MoU with Ma'aden to supply phosphatic fertilisers.    RBI releases draft directions on lending against gold collateral    Chavda Infra gains after securing Rs 73-cr order    NACL Industries jumps 57% in nine days    Deepak Builders CFO Rishabh Gupta resigns    Mphasis gets U.S. patent for quantum prediction system 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Aurobindo Pharma's arm receives permission from European Commission to market Dyrupeg
07-Apr-25   12:54 Hrs IST

The committee for medicinal products (CHMP) of the European Medicines Agency had adopted a positive opinion, recommending the approval of Dyrupeg.

Dyrupeg is a biosimilar medicine containing the active substance pegfilgrastim, intended to reduce the duration of neutropenia and prevent febrile neutropenia in adult cancer patients treated with cytotoxic chemotherapy.

Aurobindo Pharma is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.

Aurobindo Pharma reported a 10.04% decline in consolidated net profit to Rs 845.57 crore in Q3 FY25, compared to Rs 939.97 crore posted in Q3 FY24. Revenue from operations increased 8.53% year on year (YoY) to Rs 7,978.52 crore in the quarter ended 31 December 2024.

Shares of Aurobindo Pharma fell 1.40% to currently trade at Rs 1,089.35 on the BSE.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking Hit Count : 40113046
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd